Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels

Carlos Cruchaga, Caroline Graff, Huei Hsin Chiang, Jun Wang, Anthony L. Hinrichs, Noah Spiegel, Sarah Bertelsen, Kevin Mayo, Joanne B. Norton, John C. Morris, Alison Goate

Research output: Contribution to journalArticlepeer-review

125 Scopus citations


Objective: To test whether rs1990622 (TMEM106B) is associated with age at onset (AAO) in granulin (GRN) mutation carriers and with plasma GRN levels in mutation carriers and healthy, elderly individuals. Rs1990622 (TMEM106B) was identified as a risk factor for frontotemporal lobar degeneration with TAR DNA-binding protein inclusions (FTLD-TDP) in a recent genome-wide association. Design: Rs1990622 was genotyped in GRN mutation carriers and tested for association with AAO using the Kaplan-Meier method and a Cox proportional hazards model. Setting: Alzheimer's Disease Research Center. Subjects: We analyzed 50 affected and unaffected GRN mutation carriers from 4 previously reported FTLD-TDP families (HDDD1, FD1, HDDD2, and the Karolinska family). The GRN plasma levels were also measured in 73 healthy, elderly individuals. Main Outcome Measures: Age at onset and GRN plasma levels. Results: The risk allele of rs1990622 was associated with a mean decrease of the AAO of 13 years (P = 9.9 × 10-7) and with lower plasma GRN levels in both healthy older adults (P = 4 × 10-4) and GRN mutation carriers (P = .0027). Analysis of the HapMap database identified a nonsynonymous single-nucleotide polymorphism rs3173615 (T185S) in perfect linkage disequilibrium with rs1990622. Conclusions: The association of rs1990622 with AAO explains, in part, the wide range in the AAO of disease among GRN mutation carriers. We hypothesize that rs1990622 or another variant in linkage disequilibrium could act in a manner similar to APOE in Alzheimer disease, increasing risk for disease in the general population and modifying AAO in mutation carriers. Our results also suggest that genetic variation in TMEM106B may influence risk for FTLD-TDP by modulating secreted levels of GRN.

Original languageEnglish
Pages (from-to)581-586
Number of pages6
JournalArchives of Neurology
Issue number5
StatePublished - May 2011
Externally publishedYes


Dive into the research topics of 'Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels'. Together they form a unique fingerprint.

Cite this